A business in context

ONC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-13 · 0001662982-26-000006

  2. 4 · Ownership change

    Report date 2026-09-30 · 0001980648-26-000027

  3. 4 · Ownership change

    Report date 2026-09-28 · 0001662982-26-000004

  4. 4 · Ownership change

    Report date 2026-09-14 · 0001193125-26-393103

  5. 4 · Ownership change

    Report date 2026-09-08 · 0001662982-26-000002

  6. 4 · Ownership change

    Report date 2026-09-01 · 0001675628-26-000003

  7. 4 · Ownership change

    Report date 2026-08-25 · 0001739452-26-000011

  8. 8-K · Current report

    Report date 2026-08-26 · 0001651308-26-000025 · Items 2.02,9.01

  9. 4 · Ownership change

    Report date 2026-08-11 · 0001980648-26-000024

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-052878

  11. 8-K · Current report

    Report date 2026-08-05 · 0001628280-26-052877 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-06-26 · 0001651308-26-000020 · Items 8.01

  13. 8-K · Current report

    Report date 2026-06-11 · 0001651308-26-000017 · Items 5.02,5.07,9.01

  14. 8-K · Current report

    Report date 2026-05-13 · 0001651308-26-000012 · Items 8.01,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-030867

  16. 8-K · Current report

    Report date 2026-05-06 · 0001628280-26-030866 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-11 · 0001104659-26-049655

  18. 8-K · Current report

    Report date 2026-04-14 · 0001651308-26-000008 · Items 2.02,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-011946

  20. 8-K · Current report

    Report date 2026-02-26 · 0001628280-26-011941 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-12-16 · 0001651308-25-000153 · Items 1.02

  22. 8-K · Current report

    Report date 2025-12-17 · 0001651308-25-000151 · Items 5.02

  23. 8-K · Current report

    Report date 2025-11-13 · 0001651308-25-000148 · Items 1.01,2.03

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-049824

  25. 8-K · Current report

    Report date 2025-11-06 · 0001628280-25-049821 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-08-29 · 0001651308-25-000136 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-08-25 · 0001628280-25-041082 · Items 1.01,2.03,7.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001651308-25-000133

  29. 8-K · Current report

    Report date 2025-08-06 · 0001651308-25-000131 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-05-21 · 0001651308-25-000084 · Items 5.07

  31. 8-K · Current report

    Report date 2025-05-13 · 0001651308-25-000078 · Items 3.02

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001651308-25-000075

  33. 8-K · Current report

    Report date 2025-05-07 · 0001651308-25-000074 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-04-29 · 0001651308-25-000066 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2025-04-28 · 0001651308-25-000063 · Items 5.07,9.01

  36. 8-K · Current report

    Report date 2025-04-28 · 0001651308-25-000057 · Items 2.02,9.01

  37. DEF 14A · Proxy statement

    Report date 2025-05-21 · 0001104659-25-032346

  38. 10-K/A · Annual report

    Report date 2024-12-31 · 0001651308-25-000036

  39. 10-K · Annual report

    Report date 2024-12-31 · 0001651308-25-000031

  40. 8-K · Current report

    Report date 2025-02-27 · 0001651308-25-000029 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 110 transaction rows110SGrant / award: 0 transaction rows0AExercise / conversion: 48 transaction rows48MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

158 matching transaction rows. Showing 151 to 158.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-10
2026-07-14
OYLER JOHN
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option (Right to Buy)
Derivative security
152074.00.0
2026-07-08
2026-07-10
Lee Chan Henry
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
American Depositary Shares266.0213.32
2026-07-08
2026-07-10
Lee Chan Henry
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
American Depositary Shares196.0159.03
2026-07-08
2026-07-10
Lee Chan Henry
10b5-1 checkbox reported
S · Sale
Disposed
American Depositary Shares664.0302.46
2026-07-08
2026-07-10
Lee Chan Henry
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
American Depositary Shares202.0194.47
2026-07-08
2026-07-10
Lee Chan Henry
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option (Right to Buy)
Derivative security
3458.00.0
2026-07-08
2026-07-10
Lee Chan Henry
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option (Right to Buy)
Derivative security
2626.00.0
2026-07-08
2026-07-10
Lee Chan Henry
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option (Right to Buy)
Derivative security
2548.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001651308BeOne Medicines Ltd.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • BeiGene, Ltd. · former SEC name · 2015-08-28 to 2025-05-27

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$3.81B$4.09B
2023-12-31$2.46B$2.72B
2022-12-31$1.42B$1.63B
2021-12-31$1.18B$1.46B
2020-12-31$308.87M$402.11M
2019-12-31$428.21M$564.32M
2018-12-31$198.22M$265.96M
2017-12-31$238.39M$327.68M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗